Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,470 | 1,480 | 12:46 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.06. | Sequana Medical NV: Transparency Notification from Shareholders | 184 | GlobeNewswire (Europe) | Transparency Notification from Shareholders
Ghent, Belgium - 26 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment of... ► Artikel lesen | |
17.06. | Sequana Medical NV: Transparency Notification from Shareholders | 268 | GlobeNewswire (Europe) | Transparency Notification from Shareholders
Ghent, Belgium - 17 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment of... ► Artikel lesen | |
06.06. | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 337 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
Ghent, Belgium, 6 June 2025 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
SEQUANA MEDICAL Aktie jetzt für 0€ handeln | |||||
06.06. | Sequana Medical NV: Transparency Notification from Shareholders | 435 | GlobeNewswire (Europe) | Transparency Notification from Shareholders
Ghent, Belgium - 6 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment of... ► Artikel lesen | |
27.05. | Sequana Medical NV: Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders | 1.213 | GlobeNewswire (Europe) | Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders
Continued strong support from major shareholders alfapump® US commercial... ► Artikel lesen | |
22.05. | Sequana Medical NV: Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders | 321 | GlobeNewswire (Europe) | Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders
Ghent, Belgium, 22 May 2025 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or... ► Artikel lesen | |
14.05. | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 295 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
Ghent, Belgium, 14 May 2025 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
08.05. | Sequana Medical NV: Transparency Notification from Shareholders | 319 | GlobeNewswire (Europe) | Transparency Notification from Shareholders
Ghent, Belgium - 8 May 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment of drug-resistant... ► Artikel lesen | |
07.05. | Sequana Medical NV: Sequana Medical Announces The Issuance Of A Subscription Request Notice Under The Share Subscription Facility Agreement With Gem | 317 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
Ghent, Belgium, 7 May 2025 - Sequana Medical NV
(Euronext Brussels:... ► Artikel lesen | |
28.04. | Sequana Medical NV: Sequana Medical Announces New Share Capital Amount and New Number of Shares | 329 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
Ghent, Belgium, 28 April 2025 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
25.04. | Sequana Medical NV: Transparency Notification from Shareholders | 291 | GlobeNewswire (Europe) | Transparency Notification from Shareholders
Ghent, Belgium - 25 April 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment of... ► Artikel lesen | |
22.04. | Sequana Medical NV: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025 | 374 | GlobeNewswire (Europe) | Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025
Publication of Annual Report 2024
Ghent, Belgium - 22 April 2025
- Sequana Medical... ► Artikel lesen | |
14.04. | CMS proposes approval of additional payment for Sequana Medical's Alfapump | 3 | MassDevice | ||
14.04. | Sequana Medical NV: CMS Proposes Approval of Additional Payment for Sequana Medical's alfapump system in Hospital Inpatient Cases | 1.021 | GlobeNewswire (Europe) | CMS Proposes Approval of Additional Payment for Sequana Medical's alfapump® system in Hospital Inpatient Cases
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2026 Rule, expected... ► Artikel lesen | |
08.04. | Sequana Medical NV: Sequana Medical Announces New Share Capital Amount And New Number Of Shares | 586 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT
AND NEW NUMBER OF SHARES
Ghent, Belgium, 8 April 2025 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
27.03. | Sequana Medical NV: Sequana Medical to Attend the "VFB Happening 2025" in Ghent, Belgium on Saturday, 29 March 2025 | 420 | GlobeNewswire (Europe) | Sequana Medical to Attend the "VFB Happening 2025" in Ghent, Belgium on Saturday, 29 March 2025
Ghent, Belgium - 27 March 2025 - Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana... ► Artikel lesen | |
20.03. | Sequana Medical NV: Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation | 498 | GlobeNewswire (Europe) | Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation
Ghent, Belgium - 20 March 2025 - Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or... ► Artikel lesen | |
19.03. | Sequana Medical NV GAAP EPS of -€1.22, revenue of €0.106M | 2 | Seeking Alpha | ||
18.03. | Sequana Medical NV: Sequana Medical announces 2024 Full Year Results and 2025 Outlook | 830 | GlobeNewswire (Europe) | Sequana Medical announces 2024 Full Year Results and 2025 Outlook
alfapump® - US FDA approval of alfapump® for the treatment of recurrent or refractory ascites due to liver cirrhosis; US commercial... ► Artikel lesen | |
18.03. | Sequana Medical NV: Sequana Medical Obtains Convertible Financing of EUR 4.0 Million from Major Shareholders and Committed Share Subscription Facility of up to EUR 60 Million from GEM | 447 | GlobeNewswire (Europe) | Sequana Medical Obtains Convertible Financing of EUR 4.0 Million from Major Shareholders and Committed Share Subscription Facility of up to EUR 60 Million from GEM
Continued support from major shareholders... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 42,310 | -0,19 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,550 | -0,81 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" mit einem Kursziel von 60,50 Euro belassen. Die Ende Juli anstehenden Zahlen für das laufende, dritte Geschäftsquartal... ► Artikel lesen | |
CARL ZEISS MEDITEC | 53,80 | -0,09 % | ANALYSE-FLASH: UBS belässt Carl Zeiss Meditec auf 'Neutral' | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
ECKERT & ZIEGLER | 66,40 | -0,60 % | Eckert&Ziegler mit BLITZMELDUNG: Eigener Vorstand kauft massiv Anteile - Das dürfen Sie auf keinen Fall verpassen! | ||
DRAEGERWERK | 65,40 | -0,91 % | Dräger-Aktie legt um 0,15 Prozent zu (67,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Dräger zur Stunde im Plus. Der jüngste Kurs betrug 67,10 Euro. Das Wertpapier von Dräger verzeichnet aktuell ein Kursplus von 0,15 Prozent. Es... ► Artikel lesen | |
MEDTRONIC | 74,50 | -0,90 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
UNITEDHEALTH | 261,85 | -0,38 % | Neue Anleihe von UnitedHealth: A2-Rating, 5,3% Kupon | Stuttgart (www.anleihencheck.de) - Die UnitedHealth Group (ISIN US91324P1021/ WKN 869561) emittiert eine neue Unternehmensanleihe (ISIN US91324PFQ00/ WKN A4EC5N) im Umfang von 1 Mrd. Euro, so die Börse... ► Artikel lesen | |
GERRESHEIMER | 49,060 | +0,45 % | BASF, Gerresheimer, Puma, Renk Group, Suss MicroTec, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
THERMO FISHER | 365,00 | -0,52 % | Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report | ||
STRATEC | 26,700 | -0,93 % | EQS-News: STRATEC SE: Hauptversammlung beschliesst Dividendenausschüttung in Höhe von 0,60 € je Aktie | EQS-News: STRATEC SE
/ Schlagwort(e): Hauptversammlung
STRATEC-HAUPTVERSAMMLUNG BESCHLIESST DIVIDENDENAUSSCHÜTTUNG IN HÖHE VON 0,60 € JE AKTIE
27.06.2025... ► Artikel lesen | |
ESSILORLUXOTTICA | 232,50 | -1,15 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat EssilorLuxottica auf "Market-Perform" mit einem Kursziel von 245 Euro belassen. Die typischen Luxusgüterhersteller wie etwa LVMH... ► Artikel lesen | |
HIMS & HERS HEALTH | 39,610 | -2,92 % | Dr. Dennis Riedl: Bitcoin, Hims & Hers und Paypal im Check | ||
BICO GROUP | 3,248 | -0,67 % | Toni Haberthür, CEO Bico / Hilding Anders Switzerland, im Interview | von Patrick Gunti Moneycab.com: Herr Haberthür, Bico steht «für ä tüüfä gsundä Schlaaf» und ist seit Jahrzehnten die bekannteste Marke der Schweiz im Bereich hochwertiger Schlaflösungen. Wie prägt die... ► Artikel lesen | |
GERATHERM MEDICAL | 3,150 | -1,25 % | Geratherm Medical AG: GJ24 war herausfordernd, vorsichtige Prognose für GJ25; mwb research bekräftigt KAUFEN | Die Ergebnisse von Geratherm für das Geschäftsjahr 2024 zeigten einen Umsatzrückgang von 33% auf 14,0?Mio.?EUR, was in erster Linie auf deutliche Rückgänge in den Bereichen Healthcare Diagnostics und... ► Artikel lesen | |
ALCON | 74,06 | -0,80 % | Stifel reiterates Buy rating on Alcon stock amid IOL market dynamics |